BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38526941)

  • 1. Association of Helicobacter pylori CagA seropositivity with gastric precancerous lesions: a systematic review and meta-analysis.
    Qiao Z; Wang E; Bao B; Tan X; Yuan L; Wang D
    Eur J Gastroenterol Hepatol; 2024 Jun; 36(6):687-694. PubMed ID: 38526941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies.
    Camorlinga-Ponce M; Flores-Luna L; Lazcano-Ponce E; Herrero R; Bernal-Sahagún F; Abdo-Francis JM; Aguirre-García J; Muñoz N; Torres J
    Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2498-504. PubMed ID: 18768521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review with meta-analysis: association between Helicobacter pylori CagA seropositivity and odds of inflammatory bowel disease.
    Tepler A; Narula N; Peek RM; Patel A; Edelson C; Colombel JF; Shah SC
    Aliment Pharmacol Ther; 2019 Jul; 50(2):121-131. PubMed ID: 31165513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helicobacter pylori antibody responses and evolution of precancerous gastric lesions in a Chinese population.
    Pan KF; Formichella L; Zhang L; Zhang Y; Ma JL; Li ZX; Liu C; Wang YM; Goettner G; Ulm K; Classen M; You WC; Gerhard M
    Int J Cancer; 2014 May; 134(9):2118-25. PubMed ID: 24155048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori cytotoxin-associated genotype and gastric precancerous lesions.
    Plummer M; van Doorn LJ; Franceschi S; Kleter B; Canzian F; Vivas J; Lopez G; Colin D; Muñoz N; Kato I
    J Natl Cancer Inst; 2007 Sep; 99(17):1328-34. PubMed ID: 17728213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of advanced gastric precancerous lesions in Helicobacter pylori infected subjects is influenced by ABO blood group and cagA status.
    Rizzato C; Kato I; Plummer M; Muñoz N; Stein A; Jan van Doorn L; Franceschi S; Canzian F
    Int J Cancer; 2013 Jul; 133(2):315-22. PubMed ID: 23319424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori and CagA status, serum gastrin, interleukin-8 and gastric acid secretion in gastric cancer.
    Konturek SJ; Starzynska T; Konturek PC; Karczewska E; Marlicz K; Lawniczak M; Jaroszewicz-Heigelman H; Bielanski W; Hartwich A; Ziemniak A; Hahn EG
    Scand J Gastroenterol; 2002 Aug; 37(8):891-8. PubMed ID: 12229962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of gastrin in gastric cancerogenesis in Helicobacter pylori infected humans.
    Konturek PC; Konturek SJ; Bielanski W; Karczewska E; Pierzchalski P; Duda A; Starzynska T; Marlicz K; Popiela T; Hartwich A; Hahn EG
    J Physiol Pharmacol; 1999 Dec; 50(5):857-73. PubMed ID: 10695565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of
    Fernandez-Botran R; Wellmann IA; Une C; Méndez-Chacón E; Hernández de Rodas E; Bhandari B; Villagrán de Tercero CI
    Am J Trop Med Hyg; 2020 Jul; 103(1):260-265. PubMed ID: 32314688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunostimulatory membrane proteins potentiate
    Varga MG; Wood CR; Butt J; Ryan ME; You WC; Pan K; Waterboer T; Epplein M; Shaffer CL
    Gut Microbes; 2021; 13(1):1-13. PubMed ID: 33382363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection.
    Parsonnet J; Friedman GD; Orentreich N; Vogelman H
    Gut; 1997 Mar; 40(3):297-301. PubMed ID: 9135515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Helicobacter pylori CagA(+) infection in gastric cancer patients].
    Ławniczak M; Starzyńska T
    Pol Merkur Lekarski; 2002 Sep; 13(75):216-20. PubMed ID: 12474574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CagA in Barrett's oesophagus in Colombia, a country with a high prevalence of gastric cancer.
    Kudo M; Gutierrez O; El-Zimaity HM; Cardona H; Nurgalieva ZZ; Wu J; Graham DY
    J Clin Pathol; 2005 Mar; 58(3):259-62. PubMed ID: 15735156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The utility of serologic tests as biomarkers for Helicobacter pylori-associated precancerous lesions and gastric cancer varies between Latin American countries.
    Flores-Luna L; Camorlinga-Ponce M; Hernandez-Suarez G; Kasamatsu E; Martínez ME; Murillo R; Lazcano E; Torres J
    Cancer Causes Control; 2013 Feb; 24(2):241-8. PubMed ID: 23184121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between pork consumption, CagA status and IL-1B-31 genotypes in gastric cancer.
    Wang XQ; Terry PD; Cheng L; Yan H; Wang JS; Wu WA; Hu SK
    World J Gastroenterol; 2014 Jul; 20(25):8151-7. PubMed ID: 25009387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori and CagA seropositivity and its association with gastric and oesophageal carcinoma.
    Simán JH; Engstrand L; Berglund G; Forsgren A; Florén CH
    Scand J Gastroenterol; 2007 Aug; 42(8):933-40. PubMed ID: 17613922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A CagA-independent cluster of antigens related to the risk of noncardia gastric cancer: associations between Helicobacter pylori antibodies and gastric adenocarcinoma explored by multiplex serology.
    Song H; Michel A; Nyrén O; Ekström AM; Pawlita M; Ye W
    Int J Cancer; 2014 Jun; 134(12):2942-50. PubMed ID: 24259284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CagA+ Helicobacter pylori infection and gastric cancer risk in the EPIC-EURGAST study.
    Palli D; Masala G; Del Giudice G; Plebani M; Basso D; Berti D; Numans ME; Ceroti M; Peeters PH; Bueno de Mesquita HB; Buchner FL; Clavel-Chapelon F; Boutron-Ruault MC; Krogh V; Saieva C; Vineis P; Panico S; Tumino R; Nyrén O; Simán H; Berglund G; Hallmans G; Sanchez MJ; Larrãnaga N; Barricarte A; Navarro C; Quiros JR; Key T; Allen N; Bingham S; Khaw KT; Boeing H; Weikert C; Linseisen J; Nagel G; Overvad K; Thomsen RW; Tjonneland A; Olsen A; Trichoupoulou A; Trichopoulos D; Arvaniti A; Pera G; Kaaks R; Jenab M; Ferrari P; Nesi G; Carneiro F; Riboli E; Gonzalez CA
    Int J Cancer; 2007 Feb; 120(4):859-67. PubMed ID: 17131317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between Helicobacter pylori CagA status and colorectal cancer.
    Shmuely H; Passaro D; Figer A; Niv Y; Pitlik S; Samra Z; Koren R; Yahav J
    Am J Gastroenterol; 2001 Dec; 96(12):3406-10. PubMed ID: 11774957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seropositivity against Helicobacter pylori CagA in Turkish gastric cancer patients.
    Gürbüz AK; Ozel AM; Yazgan Y; Günay A; Ozdemir S; Demirtürk L; Emekdaş G
    J Clin Gastroenterol; 2001; 33(5):389-92. PubMed ID: 11606855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.